A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.
Investors are snapping up Ascendis Pharma A/S (NASDAQ:ASND) shares following the news that competitor somavaratan long-acting growth hormone is no longer a threat. …
